However, T-regs generated through mTOR inhibition can act to inhibit the anti-tumour immunity [205] and the addition of rapamycin to cancer vaccines also demonstrated an inhibitory effect [206] emphasising that the immune modulating properties of mTOR inhibitors have to be carefully considered in the design of immunotherapies. This evidence concerns the gene MTOR and cancer.